CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 187 filers reported holding CRISPR THERAPEUTICS AG in Q3 2018. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,234,545 | -3.0% | 600,012 | +20.0% | 0.42% | +2.7% |
| Q2 2023 | $28,070,000 | -24.7% | 500,000 | -39.3% | 0.41% | -24.4% |
| Q1 2023 | $37,269,520 | -11.5% | 824,000 | -20.5% | 0.54% | -26.9% |
| Q4 2022 | $42,113,400 | -30.3% | 1,036,000 | +12.1% | 0.74% | -29.8% |
| Q3 2022 | $60,383,000 | -0.6% | 924,000 | -7.6% | 1.05% | -1.2% |
| Q2 2022 | $60,770,000 | -5.5% | 1,000,000 | -2.3% | 1.06% | -14.7% |
| Q1 2022 | $64,276,000 | -4.9% | 1,024,000 | +14.8% | 1.24% | +12.4% |
| Q4 2021 | $67,596,000 | +58.9% | 892,000 | +134.7% | 1.11% | +53.6% |
| Q3 2021 | $42,533,000 | +66.3% | 380,000 | +140.5% | 0.72% | +57.2% |
| Q2 2021 | $25,579,000 | +34.6% | 158,000 | +1.3% | 0.46% | +5.0% |
| Q1 2021 | $19,009,000 | +72.4% | 156,000 | +116.7% | 0.44% | +16.3% |
| Q4 2020 | $11,024,000 | -35.4% | 72,000 | -64.7% | 0.38% | -39.4% |
| Q3 2020 | $17,063,000 | +23.5% | 204,000 | +8.5% | 0.62% | +2.1% |
| Q2 2020 | $13,816,000 | +38.0% | 188,000 | -20.3% | 0.61% | -2.1% |
| Q1 2020 | $10,009,000 | +11.0% | 236,000 | +59.5% | 0.62% | +19.0% |
| Q4 2019 | $9,014,000 | -16.7% | 148,000 | -43.9% | 0.52% | -27.5% |
| Q3 2019 | $10,821,000 | +278.6% | 264,000 | +230.0% | 0.72% | +359.6% |
| Q1 2019 | $2,858,000 | -41.8% | 80,000 | -53.5% | 0.16% | -58.1% |
| Q4 2018 | $4,914,000 | -32.6% | 172,000 | +38.7% | 0.37% | -21.8% |
| Q2 2018 | $7,286,000 | – | 124,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |